[Use of a single daily dose of tobramycin sulfate for the prevention of infections caused by the positioning of fixed drains in body cavities].
The clinical and bacterial efficiency of tobramycin sulphate administered once a day (150 mg/day) in the prevention of pleural cavity and bladder infections was evaluated by considering 30 surgical patients fitted with thoracostomic tubes or bladder catheters. Pleural cavity sterility was maintained in 74% of cases and bladder sterility was maintained or obtained in 100% of cases. These results confirm the success of the treatment.
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control*; D002408:Catheters, Indwelling / Q000009:adverse effects; D004322:Drainage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014031:Tobramycin / Q000627:therapeutic use*; D014546:Urinary Catheterization / Q000009:adverse effects*
D014031:Tobramycin
Uso della tobramicina solfato a dose unica giornaliera nella prevenzione delle infezioni da posizionamento di drenaggi a dimora in cavità corporee.